<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40868946</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Complete Revascularization in NSTE-ACS and Multivessel Disease: Clinical Outcomes and Prognostic Implications.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1299</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life15081299</ELocationID><Abstract><AbstractText>Non-ST-segment-elevation acute coronary syndrome (NSTE-ACS) often coexists with multivessel coronary artery disease (MVD), complicating treatment decisions. Current guidelines suggest complete revascularization (CR), yet robust evidence in hemodynamically stable patients remains insufficient. However, the comparative benefit of CR over incomplete revascularization (IR) in reducing ischemic events and improving cardiac function in this population is not well established. The aim of this study was to evaluate the impact of CR on all-cause mortality, cardiac death, and ischemic readmissions at 6 and 12 months, as the composite primary outcome, and to assess left ventricular ejection fraction (LVEF) improvement at discharge and hospital length of stay, as secondary outcomes. A total of 282 hemodynamically stable NSTE-ACS patients with MVD were included, of whom 218 (77.3%) underwent CR and 64 (22.7%) IR. The primary composite outcome occurred in 40.6% of IR patients versus 11.0% in the CR group at 6 months (<i>p</i> &lt; 0.001), and 68.8% vs. 22.0% at 12 months (<i>p</i> &lt; 0.001). CR was associated with significantly lower rates of all-cause and cardiac death, myocardial infarction, and unstable angina. Stroke incidence was similar. Event-free survival favored CR. Multivariable analysis identified CR and baseline LVEF as independent predictors of 12-month outcomes (HR for CR: 7.797; 95% CI: 3.961-15.348; <i>p</i> &lt; 0.001; HR for LVEF: 0.959; CI: 0.926-0.994; <i>p</i> = 0.021). These findings strongly support CR as the preferred therapeutic strategy. Future prospective randomized studies are warranted to confirm the results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muste</LastName><ForeName>Silviu Raul</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0009-0002-3229-400X</Identifier><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustea</LastName><ForeName>Cristiana</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1252-0057</Identifier><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babes</LastName><ForeName>Elena Emilia</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muste</LastName><ForeName>Francesca Andreea</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bungau</LastName><ForeName>Gabriela S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tit</LastName><ForeName>Delia Mirela</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-0296-6592</Identifier><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarce</LastName><ForeName>Alexandra Georgiana</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radu</LastName><ForeName>Andrei-Flavius</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0002-7625-8177</Identifier><AffiliationInfo><Affiliation>Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NSTE-ACS</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">complete revascularization</Keyword><Keyword MajorTopicYN="N">left ventricular ejection fraction</Keyword><Keyword MajorTopicYN="N">multivessel coronary disease</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40868946</ArticleId><ArticleId IdType="pmc">PMC12387608</ArticleId><ArticleId IdType="doi">10.3390/life15081299</ArticleId><ArticleId IdType="pii">life15081299</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghaffari S. Practical Cardiology. Elsevier; Amsterdam, The Netherlands: 2022. Non-ST-Elevation Acute Coronary Syndromes; pp. 413&#x2013;428.</Citation></Reference><Reference><Citation>Babes E.E., Zaha D.C., Tit D.M., Nechifor A.C., Bungau S., Andronie-Cioara F.L., Behl T., Stoicescu M., Munteanu M.A., Rus M., et al. Value of Hematological and Coagulation Parameters as Prognostic Factors in Acute Coronary Syndromes. Diagnostics. 2021;11:850. doi: 10.3390/diagnostics11050850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11050850</ArticleId><ArticleId IdType="pmc">PMC8151317</ArticleId><ArticleId IdType="pubmed">34065132</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R.A., Rossello X., Coughlan J.J., Barbato E., Berry C., Chieffo A., Claeys M.J., Dan G.A., Dweck M.R., Galbraith M., et al. 2023 ESC Guidelines for the Management of Acute Coronary Syndromes. Eur. Heart J. 2023;44:3720&#x2013;3826. doi: 10.1093/eurheartj/ehad191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbi M.M., Scarparo P., Tovar M.N., Masdjedi K., Daemen J., Den Dekker W., Ligthart J., Witberg K., Cummins P., Wilschut J., et al. Culprit Lesion Detection in Patients Presenting with Non-ST Elevation Acute Coronary Syndrome and Multivessel Disease. Cardiovasc. Revascularization Med. 2022;35:110&#x2013;118. doi: 10.1016/j.carrev.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2021.03.019</ArticleId><ArticleId IdType="pubmed">33839051</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit N., Rahatekar P., Rekwal L., Kuber D., Nath R.K., Aggarwal P. Target Vessel Versus Complete Revascularization in Non-ST Elevation Myocardial Infarction Without Cardiogenic Shock. Cureus. 2022;14:e23139. doi: 10.7759/cureus.23139.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23139</ArticleId><ArticleId IdType="pmc">PMC9009965</ArticleId><ArticleId IdType="pubmed">35444901</ArticleId></ArticleIdList></Reference><Reference><Citation>Elscot J.J., Kakar H., Scarparo P., den Dekker W.K., Bennett J., Schotborgh C.E., van der Schaaf R., Sabat&#xe9; M., Moreno R., Ameloot K., et al. Timing of Complete Multivessel Revascularization in Patients Presenting with Non-ST-Segment Elevation Acute Coronary Syndrome. JACC Cardiovasc. Interv. 2024;17:771&#x2013;782. doi: 10.1016/j.jcin.2024.01.278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2024.01.278</ArticleId><ArticleId IdType="pubmed">38538172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kite T.A., Ladwiniec A., Greenwood J.P., Gale C.P., Anantharam B., More R., Hetherington S.L., Khan S.Q., O&#x2019;Kane P., Rakhit R., et al. Very Early Invasive Strategy in Higher Risk Non-ST-Elevation Acute Coronary Syndrome: The RAPID NSTEMI Trial. Heart. 2024;110:500&#x2013;507. doi: 10.1136/heartjnl-2023-323513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2023-323513</ArticleId><ArticleId IdType="pmc">PMC10958296</ArticleId><ArticleId IdType="pubmed">38103913</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebert V.R., Borgaonkar S., Jia X., Nguyen H.L., Birnbaum Y., Lakkis N.M., Alam M. Meta-Analysis Comparing Multivessel Versus Culprit Coronary Arterial Revascularization for Patients with Non-ST-Segment Elevation Acute Coronary Syndromes. Am. J. Cardiol. 2019;124:1501&#x2013;1511. doi: 10.1016/j.amjcard.2019.07.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.07.071</ArticleId><ArticleId IdType="pubmed">31575424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathod K.S., Koganti S., Jain A.K., Astroulakis Z., Lim P., Rakhit R., Kalra S.S., Dalby M.C., O&#x2019;Mahony C., Malik I.S., et al. Complete Versus Culprit-Only Lesion Intervention in Patients with Acute Coronary Syndromes. J. Am. Coll. Cardiol. 2018;72:1989&#x2013;1999. doi: 10.1016/j.jacc.2018.07.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.07.089</ArticleId><ArticleId IdType="pubmed">30336821</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavasini R., Biscaglia S., Barbato E., Tebaldi M., Dudek D., Escaned J., Casella G., Santarelli A., Guiducci V., Gutierrez-Ibanes E., et al. Complete Revascularization Reduces Cardiovascular Death in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Systematic Review and Meta-Analysis of Randomized Clinical Trials. Eur. Heart J. 2020;41:4103&#x2013;4110. doi: 10.1093/eurheartj/ehz896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz896</ArticleId><ArticleId IdType="pubmed">31891653</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta S.R., Wood D.A., Storey R.F., Mehran R., Bainey K.R., Nguyen H., Meeks B., Di Pasquale G., L&#xf3;pez-Send&#xf3;n J., Faxon D.P., et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N. Engl. J. Med. 2019;381:1411&#x2013;1421. doi: 10.1056/NEJMoa1907775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1907775</ArticleId><ArticleId IdType="pubmed">31475795</ArticleId></ArticleIdList></Reference><Reference><Citation>Diletti R., den Dekker W.K., Bennett J., Schotborgh C.E., van der Schaaf R., Sabat&#xe9; M., Moreno R., Ameloot K., van Bommel R., Forlani D., et al. Immediate versus Staged Complete Revascularisation in Patients Presenting with Acute Coronary Syndrome and Multivessel Coronary Disease (BIOVASC): A Prospective, Open-Label, Non-Inferiority, Randomised Trial. Lancet. 2023;401:1172&#x2013;1182. doi: 10.1016/S0140-6736(23)00351-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00351-3</ArticleId><ArticleId IdType="pubmed">36889333</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardella G., Lucisano L., Garbo R., Pennacchi M., Cavallo E., Stio R.E., Calcagno S., Ugo F., Boccuzzi G., Fedele F., et al. Single-Staged Compared with Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial. J. Am. Coll. Cardiol. 2016;67:264&#x2013;272. doi: 10.1016/j.jacc.2015.10.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.10.082</ArticleId><ArticleId IdType="pubmed">26796390</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq V., Serruys P.W., Bourantas C.V., Zhang Y., Muramatsu T., Feldman T., Holmes D.R., Mack M., Morice M.C., St&#xe5;hle E., et al. Quantification of Incomplete Revascularization and Its Association with Five-Year Mortality in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score. Circulation. 2013;128:141&#x2013;151. doi: 10.1161/CIRCULATIONAHA.113.001803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.001803</ArticleId><ArticleId IdType="pubmed">23766350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T.T., Patel U.D., Chang T.I., Kennedy K.F., Masoudi F.A., Matheny M.E., Kosiborod M., Amin A.P., Messenger J.C., Rumsfeld J.S., et al. Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights from the NCDR Cath-PCI Registry. JACC Cardiovasc. Interv. 2014;7:1&#x2013;9. doi: 10.1016/j.jcin.2013.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2013.06.016</ArticleId><ArticleId IdType="pmc">PMC4122507</ArticleId><ArticleId IdType="pubmed">24456715</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli G., Scalone G., Lerman A., Crea F. Coronary Microvascular Obstruction in Acute Myocardial Infarction. Eur. Heart J. 2016;37:1024&#x2013;1033. doi: 10.1093/eurheartj/ehv484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv484</ArticleId><ArticleId IdType="pubmed">26364289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantea-Ro&#x219;an L.R., Bungau S.G., Radu A.-F., Pantea V.A., Moisi M.I., Vesa C.M., Behl T., Nechifor A.C., Babes E.E., Stoicescu M., et al. A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon. Diagnostics. 2022;12:932. doi: 10.3390/diagnostics12040932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12040932</ArticleId><ArticleId IdType="pmc">PMC9029120</ArticleId><ArticleId IdType="pubmed">35453980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., Steg P.G., Morel M., Mauri L., Vranckx P., et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation. 2007;115:2344&#x2013;2351. doi: 10.1161/CIRCULATIONAHA.106.685313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.685313</ArticleId><ArticleId IdType="pubmed">17470709</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkin C.J., George V., Ghobrial M.S.A., Krishnan A., Siotia A., Raina T., Morton A.C., Gunn J. Residual SYNTAX Score after PCI for Triple Vessel Coronary Artery Disease: Quantifying the Adverse Effect of Incomplete Revascularisation. EuroIntervention. 2013;8:1286&#x2013;1295. doi: 10.4244/EIJV8I11A197.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV8I11A197</ArticleId><ArticleId IdType="pubmed">23538157</ArticleId></ArticleIdList></Reference><Reference><Citation>IBM SPSS Statistics 25.  [(accessed on 18 July 2025)].  Available online:  https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-25.</Citation></Reference><Reference><Citation>Desperak P., Hawranek M., G&#x105;sior P., Desperak A., Lekston A., G&#x105;sior M. Long-Term Outcomes of Patients with Multivessel Coronary Artery Disease Presenting Non-ST-Segment Elevation Acute Coronary Syndromes. Cardiol. J. 2019;26:157&#x2013;168. doi: 10.5603/CJ.a2017.0110.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2017.0110</ArticleId><ArticleId IdType="pmc">PMC8086658</ArticleId><ArticleId IdType="pubmed">28980282</ArticleId></ArticleIdList></Reference><Reference><Citation>Faro D.C., Laudani C., Agnello F.G., Ammirabile N., Finocchiaro S., Legnazzi M., Mauro M.S., Mazzone P.M., Occhipinti G., Rochira C., et al. Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes with Multivessel Coronary Disease: A Systematic Review. JACC Cardiovasc. Interv. 2023;16:2347&#x2013;2364. doi: 10.1016/j.jcin.2023.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2023.07.043</ArticleId><ArticleId IdType="pubmed">37821180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchini E., Basile M., Bianchini F., Zito A., Romagnoli E., Aurigemma C., Paraggio L., Lunardi M., Laborante R., Fracassi F., et al. Multivessel Revascularization in Non-ST Segment Elevation Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 182,798 Patients. Int. J. Cardiol. 2024;413:132392. doi: 10.1016/j.ijcard.2024.132392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2024.132392</ArticleId><ArticleId IdType="pubmed">39067526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez D&#xed;az V.A., Routledge H., Malik F.-T.-N., Hildick-Smith D., Gu&#xe9;d&#xe8;s A., Baello P., Kuramitsu S., Das R., Dewilde W., Portales J.F., et al. Complete versus Incomplete Revascularization in Patients with a Non-ST-Elevation Myocardial Infarction: Analysis from the e-ULTIMASTER Registry. Cardiovasc. Revascularization Med. 2025;75:25&#x2013;30. doi: 10.1016/j.carrev.2024.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2024.07.011</ArticleId><ArticleId IdType="pubmed">39079857</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuca R.-D., Covic A.M., Brinza C., Floria M., Statescu C., Covic A., Burlacu A. Updated Strategies in Non-Culprit Stenosis Management of Multivessel Coronary Disease&#x2014;A Contemporary Review. Medicina. 2024;60:263. doi: 10.3390/medicina60020263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina60020263</ArticleId><ArticleId IdType="pmc">PMC10890538</ArticleId><ArticleId IdType="pubmed">38399550</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann A.A.W., Tavella R., Air T.M., Mishra A., Montarello N.J., Arstall M., Zeitz C., Worthley M.I., Beltrame J.F., Psaltis P.J. Prevalence and Real-World Management of NSTEMI with Multivessel Disease. Cardiovasc. Diagn. Ther. 2022;12:1&#x2013;11. doi: 10.21037/cdt-21-518.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt-21-518</ArticleId><ArticleId IdType="pmc">PMC8898694</ArticleId><ArticleId IdType="pubmed">35282665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad Y., Howard J.P., Arnold A., Prasad M., Seligman H., Cook C.M., Warisawa T., Shun-Shun M., Ali Z., Parikh M.A., et al. Complete Revascularization by Percutaneous Coronary Intervention for Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials. J. Am. Heart Assoc. 2020;9:e015263. doi: 10.1161/JAHA.119.015263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.015263</ArticleId><ArticleId IdType="pmc">PMC7429036</ArticleId><ArticleId IdType="pubmed">32476540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax J.J., Poldermans D., Elhendy A., Cornel J.H., Boersma E., Rambaldi R., Roelandt J.R.T.C., Fioretti P.M. Improvement of Left Ventricular Ejection Fraction, Heart Failure Symptoms and Prognosis after Revascularization in Patients with Chronic Coronary Artery Disease and Viable Myocardium Detected by Dobutamine Stress Echocardiography. J. Am. Coll. Cardiol. 1999;34:163&#x2013;169. doi: 10.1016/S0735-1097(99)00157-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(99)00157-6</ArticleId><ArticleId IdType="pubmed">10400006</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahroug M.S.A., Mustafa S.A., Farag S.I., Ateya W.M. Short Term Effect of Total Revascularization on Left Ventricular Recovery in NSTEMI Patients: Speckle Tracking Study. Benha J. Appl. Sci. 2022;7:113&#x2013;116. doi: 10.21608/bjas.2022.293429.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/bjas.2022.293429</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagel N.D., van Nooijen F.C., Maarse M., Slagboom T., Herrman J.P., van der Schaaf R.J., Amoroso G., Patterson M.S., Laarman G.J., Suttorp M.J., et al. Five-Year Results of the Complete versus Culprit Vessel Percutaneous Coronary Intervention in Multivessel Disease Using Drug-Eluting Stents II (CORRECT II) Study: A Prospective, Randomised Controlled Trial. Netherlands Heart J. 2019;27:310&#x2013;320. doi: 10.1007/s12471-019-1252-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-019-1252-3</ArticleId><ArticleId IdType="pmc">PMC6533316</ArticleId><ArticleId IdType="pubmed">30868547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno F., Marengo G., De Filippo O., Wanha W., Leonardi S., Raposeiras Roubin S., Fabris E., Popovic M., Giannino G., Truffa A., et al. Impact of Complete Revascularization on Development of Heart Failure in Patients with Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry. J. Am. Heart Assoc. 2023;12:e028475. doi: 10.1161/JAHA.122.028475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.028475</ArticleId><ArticleId IdType="pmc">PMC10492970</ArticleId><ArticleId IdType="pubmed">37489724</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmerini T., Dangas G., Mehran R., Caixeta A., G&#xe9;n&#xe9;reux P., Fahy M.P., Xu K., Cristea E., Lansky A.J., Stone G.W. Predictors and Implications of Stent Thrombosis in Non-ST-Segment Elevation Acute Coronary Syndromes the ACUITY Trial. Circ. Cardiovasc. Interv. 2011;4:577&#x2013;584. doi: 10.1161/CIRCINTERVENTIONS.111.963884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.111.963884</ArticleId><ArticleId IdType="pubmed">22028471</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuculi F., Banning A.P., Abizaid A., Bartorelli A.L., Baux A.C., Dzav&#xed;k V., Ellis S., Gao R., Holmes D., Jeong M.H., et al. Outcomes in Patients Undergoing Multivessel Percutaneous Coronary Intervention Using Sirolimus-Eluting Stents: A Report from the e-SELECT Registry. EuroIntervention. 2011;7:962&#x2013;968. doi: 10.4244/EIJV7I8A152.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV7I8A152</ArticleId><ArticleId IdType="pubmed">22157482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan E.L., Samadashvili Z., Walford G., Holmes D.R.J., Jacobs A.K., Stamato N.J., Venditti F.J., Sharma S., King S.B., 3rd Culprit Vessel Percutaneous Coronary Intervention versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients with Multivessel Disease. JACC Cardiovasc. Interv. 2010;3:22&#x2013;31. doi: 10.1016/j.jcin.2009.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2009.10.017</ArticleId><ArticleId IdType="pubmed">20129564</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>